Immunity for Health: Vaccines & Immunotherapy

16–17 Oct 2024 | RodeBol Events

Josipa Bello

Business Development Lead

AstriVax

Leuven, Belgium

7 profile visits

About me

My organisation

We are AstriVax, a cutting-edge biotechnology company focused on developing innovative vaccines based on novel technology platform, PLLAV (DNA launched live attenuated virus) to address global health challenges. Our team of dedicated scientists and researchers work to create safe and effective vaccine solutions . At AstriVax, we are committed to pushing the boundaries of science to protect and improve the health of people everywhere.

Additional questions

How would you categorise yourself?

Business Developer

Organisation Type

Biotech company/R&D

Areas of expertise

Research and developmentPreclinical research Vaccine R&DClinical development and trials

Therapeutic areas

Infectious diseases

1. I accept the General Terms & Conditions and Privacy Statement, available on flandersvaccine.be and agree that pictures can be taken at the event and be used for Flanders Vaccine communication purposes.

I agree